Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions

Pharmaceutical compounds often exist in multiple crystalline forms, known as polymorphs. These forms can differ in stability, solubility, and bioavailability. Understanding how these forms change is important for drug development. Prior research has shown that mechanical and environmental factors influence polymorphic transitions. However, the exact mechanisms of these changes remain unclear. This uncertainty drives the need for detailed studies on how unit operations and storage conditions affect polymorphs. No prior work has fully resolved the impact of pressure, shear, and humidity on these transitions. The field lacks a comprehensive framework for predicting and controlling polymorphic transformations. This gap motivated the current investigation into the factors that induce these changes. The study aims to clarify the role of process variables in altering the crystalline state of APIs.

The study aims to investigate how mechanical and environmental factors influence the polymorphic transformations of active pharmaceutical ingredients. These transformations can affect drug performance and formulation stability. The specific problem is understanding how unit operations and storage conditions alter the crystalline state of APIs. The motivation comes from the need to predict and control these changes in drug manufacturing. The study focuses on identifying the role of pressure, shear, and humidity in inducing polymorphic transitions. It also explores how storage conditions, such as temperature and relative humidity, affect API crystallinity. The goal is to provide insights into the mechanisms of these transformations. This information is essential for optimizing pharmaceutical processes and ensuring product quality.

The research involved analyzing the effects of various unit operations on API crystallinity. Techniques like granulation, milling, and compression were studied to observe polymorphic transitions. The study used controlled pressure, shear, and temperature conditions to simulate industrial processes. Crystal habit changes were monitored using analytical methods like X-ray diffraction. Storage conditions were tested by varying temperature and relative humidity levels. The impact of these conditions on dehydration, desolvation, and molecular mobility was assessed. The study also examined how these changes affect API handling in subsequent operations. Data was collected to determine the likelihood of polymorphic transformations under different scenarios.

The study found that mechanical forces like pressure and shear can induce polymorphic transitions in APIs. These changes were observed during granulation, milling, and compression processes. Temperature fluctuations during storage were linked to dehydration or desolvation of crystals. High humidity conditions increased molecular mobility, leading to crystallization or polymorphic changes. The results suggest that storage conditions significantly influence API crystallinity. The study also showed that crystal habit alterations can affect API handling in subsequent operations. Specific temperature and humidity thresholds were identified as critical factors. These findings provide a clearer understanding of how process variables and storage conditions impact polymorphic transformations.

The authors propose that mechanical and environmental factors play a significant role in polymorphic transformations of APIs. They suggest that pressure, shear, and temperature can alter crystal habit during unit operations. The study indicates that storage conditions like temperature and humidity influence API crystallinity. The findings suggest that dehydration and desolvation are likely outcomes of temperature changes during storage. The authors propose that high humidity increases molecular mobility, leading to crystallization or polymorphic changes. These conclusions are based on the observed effects of process variables and storage conditions. The study highlights the importance of controlling these factors in pharmaceutical manufacturing. The authors suggest that these findings may help in optimizing drug formulation processes.